Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

376
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
376
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

257
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
257
Pharmacovigilance01:19

Pharmacovigilance

833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

128
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
128
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

984
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
984

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Can Technology Simplify Aging Care-or Just Shift the Complexity?

The Senior care pharmacist·2026
Same author

A Randomized Controlled Trial of Self-Guided Digital Written Imaginal Exposure Therapy for Eating Disorders in Patients Recently Discharged From Higher Level Specialty Eating Disorder Care.

The International journal of eating disorders·2026
Same author

Comprehensive Geriatric Assessment and Medication "Appropriateness".

The Senior care pharmacist·2026
Same author

Factors Associated with Healthcare Utilization in Children with Sickle Cell Disease in Saudi Arabia.

International journal of environmental research and public health·2026
Same author

Caring for the Caregiver.

The Senior care pharmacist·2026
Same author

Reflecting on the Value of Mentors.

The Senior care pharmacist·2026

相关实验视频

Updated: Jul 4, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

用观察数据评估药物相互作用的统计方法.

Qian Xu1,2, Demetra Antimisiaris3, Maiying Kong1

  • 1Department of Bioinformatics and Biostatistics, University of Louisville School of Public Health and Information Sciences, Louisville, KY, USA.

Journal of applied statistics
|January 29, 2024
PubMed
概括

本研究引入了边缘结构模型,以评估多种药物的因果作用和相互作用,这对于管理复杂疾病和最大限度地减少不良药物事件至关重要.

关键词:
药物相互作用 药物相互作用一般化倾向分数的概括性得分.边际结构模型是边际结构模型.多项逻辑回归多项逻辑回归

更多相关视频

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

相关实验视频

Last Updated: Jul 4, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

科学领域:

  • 药理学和药理学流行病学
  • 生物统计和健康数据科学 数据科学

背景情况:

  • 多重药物使用在患有多种疾病的患者中很常见,这可能导致严重副作用的风险.
  • 组合治疗对于管理癌症和慢性疾病等严重疾病至关重要.
  • 电子健康记录为分析药物相互作用提供了宝贵的数据.

研究的目的:

  • 提出和验证边缘结构模型来评估两种药物的平均治疗效果和因果相互作用.
  • 在使用观察数据评估药物效应时控制混变量.
  • 为了解复杂的药物相互作用提供一个强大的统计框架.

主要方法:

  • 使用边缘结构模型来估计因果关系和相互作用.
  • 采用治疗权重的逆概率 (IPTW) 方法来进行权衡的概率估计.
  • 进行模拟研究,以评估拟议方法的一致性和性能.

主要成果:

  • 建议的边缘结构模型始终评估因果参数.
  • 模拟研究证实了该方法在处理混时的可靠性.
  • 案例研究证明了在分析药物对患者结果和生物标志物的影响时的应用.

结论:

  • 边缘结构模型为观察性研究中评估因果药物相互作用提供了可靠的方法.
  • 该IPTW方法有效控制混,使得平均治疗效果的准确估计.
  • 这种方法可以通过阐明药物在现实患者群体中的联合作用来告知临床实践.